About this trial
This study aims to evaluate the effect of serratus posterior superior intercostal plane (SPSIP) block on postoperative pain, opioid consumption, and analgesic requirements in patients undergoing mastectomy and axillary lymph node dissection
Eligibility criteria
Qualifiers
Female patients aged 18-65 years
ASA physical status I-III
Scheduled for elective unilateral mastectomy with axillary lymph node dissection under general anesthesia
Able to understand and use the Numeric Rating Scale (NRS) for pain assessment
Disqualifiers
Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine)
Coagulopathy, thrombocytopenia (<100,000/mm³), or ongoing anticoagulant/antiplatelet therapy that cannot be discontinued
Infection or skin lesion at the injection site
Planned bilateral surgery or additional major surgical procedures
Trial design
Treatments tested in this trial
- SPSIP Block With Bupivacaine
- SPSIP Block With Saline